Back
Keros Therapeutics 10K Form
Sell
28
KROS
Keros Therapeutics
Last Price:
32.89
Seasonality Move:
57.17%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive KROS News And Ratings
See the #1 stock for the next 7 days that we like better than KROS
KROS Financial Statistics
Sales & Book Value
| Annual Sales: | $20.1M |
|---|---|
| Cash Flow: | $-31.14M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $11.00 |
| Price / Book: | 2.99 |
Profitability
| EPS (TTM): | -4.54000 |
|---|---|
| Net Income (TTM): | $-126.54M |
| Gross Margin: | -- |
| Return on Equity: | 0% |
| Return on Assets: | 0% |
Keros Therapeutics Earnings Forecast
Key Keros Therapeutics Financial Ratios
- The Interest Expense is 0.00% of Operating Income.
- Per Share Earnings over the last 5 years have been positive in 1 years.
Keros Therapeutics Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Healthcare |
| Current Symbol: | KROS |
| CUSIP: | 492327 |
| Website: | kerostx.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 0 |
| Quick Ratio: | 0 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
KROS Technical Analysis vs Fundamental Analysis
Sell
28
Keros Therapeutics (KROS)
is a Sell
Is Keros Therapeutics a Buy or a Sell?
-
Keros Therapeutics stock is rated a Sell
The current Keros Therapeutics [KROS] share price is $32.85. The Score for KROS is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.